These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9834051)

  • 21. Phenotyping of drug metabolism in infants and children: potentials and problems.
    Rane A
    Pediatrics; 1999 Sep; 104(3 Pt 2):640-3. PubMed ID: 10469807
    [No Abstract]   [Full Text] [Related]  

  • 22. High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.
    Kaneko A; Kaneko O; Taleo G; Björkman A; Kobayakawa T
    Lancet; 1997 Mar; 349(9056):921-2. PubMed ID: 9093256
    [No Abstract]   [Full Text] [Related]  

  • 23. Direct evidence for the higher frequency of CYP2C19 allelic heterozygotes in Chinese subjects than in white subjects.
    Xie HG
    Clin Pharmacol Ther; 1997 Dec; 62(6):691-2. PubMed ID: 9433397
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonlinear kinetics after high-dose omeprazole caused by saturation of genetically variable CYP2C19.
    Rost KL; Roots I
    Hepatology; 1996 Jun; 23(6):1491-7. PubMed ID: 8675169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population.
    de Morais SM; Goldstein JA; Xie HG; Huang SL; Lu YQ; Xia H; Xiao ZS; Ile N; Zhou HH
    Clin Pharmacol Ther; 1995 Oct; 58(4):404-11. PubMed ID: 7586932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study.
    Balian JD; Sukhova N; Harris JW; Hewett J; Pickle L; Goldstein JA; Woosley RL; Flockhart DA
    Clin Pharmacol Ther; 1995 Jun; 57(6):662-9. PubMed ID: 7781266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CYP2C19 enzyme polymorphism.
    Wedlund PJ
    Pharmacology; 2000 Sep; 61(3):174-83. PubMed ID: 10971203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype.
    Tanaka M; Ohkubo T; Otani K; Suzuki A; Kaneko S; Sugawara K; Ryokawa Y; Hakusui H; Yamamori S; Ishizaki T
    Clin Pharmacol Ther; 1997 Dec; 62(6):619-28. PubMed ID: 9433390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
    Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
    Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AmpliChip CYP450 test.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):71-2. PubMed ID: 16103869
    [No Abstract]   [Full Text] [Related]  

  • 31. Do racial or populational differences exist in coronary anomalies?
    Barriales-Villa R; Morís C
    Int J Cardiol; 2001 Nov; 81(1):89-90. PubMed ID: 11690670
    [No Abstract]   [Full Text] [Related]  

  • 32. Cultural competence: cardiovascular medications.
    Kudzma EC
    Prog Cardiovasc Nurs; 2001; 16(4):152-60, 169. PubMed ID: 11684906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic prescribing.
    Kuebler K
    Am J Nurs; 2003 Jan; 103(1):16; author reply 16. PubMed ID: 12549473
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of genetics in understanding racial and ethnic health disparities.
    Bonham VL
    JAAPA; 2010 Jan; 23(1):49-50. PubMed ID: 20135925
    [No Abstract]   [Full Text] [Related]  

  • 35. The ethics of characterizing difference: guiding principles on using racial categories in human genetics.
    Lee SS; Mountain J; Koenig B; Altman R; Brown M; Camarillo A; Cavalli-Sforza L; Cho M; Eberhardt J; Feldman M; Ford R; Greely H; King R; Markus H; Satz D; Snipp M; Steele C; Underhill P
    Genome Biol; 2008; 9(7):404. PubMed ID: 18638359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidating the role of the gastrointestinal microbiota in racial and ethnic health disparities.
    Byrd DA; Carson TL; Williams F; Vogtmann E
    Genome Biol; 2020 Aug; 21(1):192. PubMed ID: 32746938
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethnicity: Diversity is future for genetic analysis.
    Carlson CS
    Nature; 2016 Dec; 540(7633):341. PubMed ID: 27974770
    [No Abstract]   [Full Text] [Related]  

  • 38. Relevance of ethnic differences in factor XIII activity on laboratory reference ranges.
    Wong WH; Tan CK; Ho LP; Tan CW; Kaur H; Lee LH; Ng HJ
    Int J Lab Hematol; 2017 Oct; 39(5):e113-e116. PubMed ID: 28488800
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene politics.
    Maddern S
    Nurs Stand; 2005 Oct 19-25; 20(6):32-3. PubMed ID: 16268311
    [No Abstract]   [Full Text] [Related]  

  • 40. When race matters.
    Litt IF
    J Adolesc Health; 2001 Nov; 29(5):311. PubMed ID: 11691590
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.